Fig. 2From: Impact of the perioperative inotropic support in grown-up congenital heart patients undergoing cardiac surgery: a propensity score adjusted analysisDistribution of the inotropic-vasoactive support among the Milrinone and the Levosimendan groups. Overall, 49.3% of the patients received one inotropic-vasoactive agent, and 23.8% received two agentsBack to article page